| NCT Number | NCT03746197 |
| Lead Sponsor | National Jewish Health
Collaborators: Novartis Pharmaceuticals, Akili Interactive Labs, Inc. |
| Conditions | Lupus Erythematosus, Systemic |
| Enrollment | 60 participants |
| Start Date | 2018-06-06 |
| Primary Completion | 2019-09-30 (estimated) |
| Study Completion | 2020-07-01 (estimated) |
| Updated on ClinicalTrials.gov | 2020-01-13 |